Study: Protein Mutation Protects Indian HIV Patients From AIDS Dementia
This article was originally published in PharmAsia News
Executive Summary
A research team has determined India has a relatively low incidence of AIDS-induced dementia because of a mutation that occurs in Indian patients. Four percent of Indians infected with HIV get AIDS-induced dementia, while 45 percent of HIV patients in the West get the dementia, the study determined. Researchers ascribed the difference to Tat, a neuro-toxic protein in the AIDS virus that mutates naturally. The Indian strain, HIV1-C is the only strain of 10 that undergoes the mutation that leads to Tat being ineffective in Indians infected with HIV. (Click here for more
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.